PTC Therapeutics, a drug development company based in South Plainfield, N.J., said it will lay off 94 employees at its corporate office by Aug. 21, according to a notice filed in the state. 

The FDA granted Pfizer's popular COVID-19 antiviral treatment, Paxlovid, full approval on May 25.

Some hospitals are scraping vials to offer enough cancer drugs for their patients as the U.S. faces about two dozen chemotherapy shortages.

Billionaire and Shark Tank investor Mark Cuban will soon start selling five Pfizer brand-name drugs through his pharmaceutical company, Mark Cuban Cost Plus Drug Co. 

Following the Federal Trade Commission's expanded probe into pharmacy benefit managers and their group purchasing organizations, Drug Channels listed five possible reasons why PBMs create GPOs.

Mark Cuban Cost Plus Drug Co. lowered prices for 18 drugs May 23, according to a company tweet. 

There is not enough supply for usual ordering of ribavirin inhalation solutions, a drug for severe pediatric pneumonia cases caused by respiratory syncytial virus, according to a May 23 post from the American Society of Health-System Pharmacists. 

On May 23, the FDA approved a new drug intended to treat hospital-acquired pneumonia and ventilator-associated pneumonia caused by Acinetobacter baumannii-calcoaceticus, a critical bacterial pathogen. 

The American Hospital Association and American Society of Health-System Pharmacists, along with four other groups, recently sent a letter to the House Energy and Commerce Committee's Health Subcommittee opposing two bill amendments that would affect 340B hospitals and stakeholders.

Moderna has purchased a new biomanufacturing facility in Marlborough, Mass., which will be designated for mRNA manufacturing. It is anticipated to open in September 2024, according to an April 28 report from the Worcester Business Journal. 

A pill version of Ozempic (semaglutide), a Type 2 diabetes drug in high demand for its off-label use for weight loss, resulted in 15.1 percent weight loss among phase 3 study participants. 

In U.S. News' newest over-the-counter medicine and health products ranking, the news organization collaborated with The Harris Poll to determine what 350 pharmacists recommend among more than 700 products. 

One pharmacy benefit manager makes up one-third of the market, according to a May 23 report from Drug Channels. 

Teva Pharmaceuticals said it will shrink some of its generic drug manufacturing as the Israel-based drugmaker reports $20.7 billion in debt. 

The American Society of Health-System Pharmacists has announced the inaugural launch of a national membership organization aimed at supporting and advocating for policies that advance the role of pharmacist technicians in patient care.

The FDA on May 19 approved the first drug to treat patients with dystrophic epidermolysis bullosa — a rare genetic disorder that causes fragile skin and persistent sores. 

Corewell Health, based in Grand Rapids and Southfield, Mich., named Jason McCarthy, PharmD, as its next chief pharmacy officer May 17. 

A 2003 law prohibits Medicare Part D from covering weight loss drugs, but if that changes, this class of popular medications could cost Medicare tens of billions, the KFF reported May 18. 

A Buffalo, N.Y.-based biopharmaceutical company filed for bankruptcy and is attempting to sell its assets before a July 1 shutdown, according to court documents. 

The Federal Trade Commission is widening its inquiry into the pharmacy benefit manager industry to include two group purchasing organizations that negotiate drug rebates on behalf of PBMs.